首页 正文

Protective Mechanisms of SGLTi in Ischemic Heart Disease

{{output}}
Ischemic heart disease (IHD) is a common clinical cardiovascular disease with high morbidity and mortality. Sodium glucose cotransporter protein inhibitor (SGLTi) is a novel hypoglycemic drug. To date, both clinical trials and animal experiments have shown tha... ...